Can Clinical Guidelines Afford to Ignore Cost Effectiveness? An Ethical Perspective

Kenneth Boyd, Peter Hall

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalPharmacoEconomics
DOIs
Publication statusPublished - 20 Feb 2016

Cite this